Jacobson Pharma Corporation Limited (02633) announced its monthly return on movements in securities for the period ended 31 October 2025. The total authorised share capital remained at 5,000,000,000 ordinary shares at HKD0.01 par value, amounting to HKD50,000,000 in total.

As of the end of October, the company’s issued share count stayed at 2,000,221,000 ordinary shares, reflecting no increases or decreases during the reporting period. No new funds were raised or shares issued through any share option exercises. According to the company, the share option scheme last adopted on 30 August 2016 remains in place with a total of 138,000,000 shares authorized for potential issuance.

The filing confirmed that no warrants, convertible securities, or other share issuance arrangements were in effect during the month. The company also verified that all regulatory requirements and listing rules were complied with throughout the period.